{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:26:25Z","timestamp":1781223985804,"version":"3.54.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jbo.2020.100327","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T11:49:04Z","timestamp":1603280944000},"page":"100327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3534-6215","authenticated-orcid":false,"given":"Shuai-Shuai","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7709-3925","authenticated-orcid":false,"given":"Guo-Xun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/nyas.13038","article-title":"Multiple myeloma in the marrow: pathogenesis and treatments","volume":"1364","author":"Fairfield","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"Suppl 12","key":"10.1016\/j.jbo.2020.100327_b0010","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ijc.22718","article-title":"Multiple myeloma: a review of the epidemiologic literature","volume":"120","author":"Alexander","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.jbo.2020.100327_b0015","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/leu.2016.380","article-title":"Trends in overall survival and costs of multiple myeloma, 2000\u20132014","volume":"31","author":"Fonseca","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.jbo.2020.100327_b0020","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3904\/kjim.2015.408","article-title":"Recent advances in multiple myeloma: a Korean perspective","volume":"31","author":"Hong","year":"2016","journal-title":"Korean J Intern Med"},{"issue":"3","key":"10.1016\/j.jbo.2020.100327_b0025","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa1709974","article-title":"Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance","volume":"378","author":"Kyle","year":"2018","journal-title":"The New England journal of medicine"},{"issue":"6","key":"10.1016\/j.jbo.2020.100327_b0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.hoc.2007.08.005","article-title":"Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple Myeloma","volume":"21","author":"Kyle","year":"2007","journal-title":"Hematol. Oncol. Clin. North Am."},{"issue":"22","key":"10.1016\/j.jbo.2020.100327_b0035","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.jbo.2020.100327_b0040","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2174\/1568009617666170214104426","article-title":"Immunomodulatory Drugs (IMiDs) in Multiple Myeloma","volume":"17","author":"Raza","year":"2017","journal-title":"Curr. Cancer Drug Targets"},{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0045","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.htct.2018.07.003","article-title":"New proteasome inhibitors in the treatment of multiple myeloma","volume":"41","author":"Hungria","year":"2019","journal-title":"Hematol Transfus Cell Ther"},{"issue":"23","key":"10.1016\/j.jbo.2020.100327_b0050","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1182\/blood-2016-09-692954","article-title":"MGUS to myeloma: a mysterious gammopathy of underexplored significance","volume":"128","author":"Dhodapkar","year":"2016","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jbo.2020.100327_b0055","first-page":"236","article-title":"microRNAs: a newly described class of encoded molecules that play a role in health and disease","volume":"14","author":"Felekkis","year":"2010","journal-title":"Hippokratia"},{"issue":"7","key":"10.1016\/j.jbo.2020.100327_b0060","first-page":"2963","article-title":"Translating the Untranslated","volume":"195","author":"Schwerk","year":"2015","journal-title":"Region."},{"issue":"5","key":"10.1016\/j.jbo.2020.100327_b0065","first-page":"6094","article-title":"The potential function of microRNAs as biomarkers and therapeutic targets in multiple myeloma","volume":"15","author":"Zhu","year":"2018","journal-title":"Oncology letters"},{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clinical epigenetics"},{"issue":"30","key":"10.1016\/j.jbo.2020.100327_b0075","first-page":"10513","volume":"105","author":"Mitchell","year":"2008","journal-title":"Circulating microRNAs as stable blood-based markers for cancer detection."},{"issue":"11","key":"10.1016\/j.jbo.2020.100327_b0080","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.3390\/cancers11111738","article-title":"The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma","volume":"11","author":"Handa","year":"2019","journal-title":"Cancers"},{"issue":"35","key":"10.1016\/j.jbo.2020.100327_b0085","doi-asserted-by":"crossref","first-page":"e12081","DOI":"10.1097\/MD.0000000000012081","article-title":"The expression and role of miR-181a in multiple myeloma","volume":"97","author":"Yuan","year":"2018","journal-title":"Medicine"},{"issue":"15","key":"10.1016\/j.jbo.2020.100327_b0090","doi-asserted-by":"crossref","first-page":"19589","DOI":"10.18632\/oncotarget.7319","article-title":"Serum high expression of miR-214 and miR-135b as novel predictor for myeloma bone disease development and prognosis","volume":"7","author":"Hao","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0095","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1038\/bcj.2011.51","article-title":"Downregulated plasma miR-92a levels have clinical impact on multiple myeloma and related disorders","volume":"2","author":"Yoshizawa","year":"2012","journal-title":"Blood cancer journal"},{"issue":"6","key":"10.1016\/j.jbo.2020.100327_b0100","doi-asserted-by":"crossref","first-page":"e23233","DOI":"10.1002\/jcla.23233","article-title":"Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"34","author":"Li","year":"2020","journal-title":"Journal of clinical laboratory analysis"},{"issue":"6","key":"10.1016\/j.jbo.2020.100327_b0105","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1007\/s00432-019-02896-1","article-title":"Clinical significance of circulatory microRNA-203 in serum as novel potential diagnostic marker for multiple myeloma","volume":"145","author":"Gupta","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.jbo.2020.100327_b0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann. Intern. Med."},{"issue":"21","key":"10.1016\/j.jbo.2020.100327_b0115","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V124.21.2043.2043","article-title":"Circulating miR-130a in multiple myeloma and extramedullary myeloma patients","volume":"124","author":"Kubiczkova-Besse","year":"2014","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jbo.2020.100327_b0120","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23233","article-title":"Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"issue":"35","key":"10.1016\/j.jbo.2020.100327_b0125","doi-asserted-by":"crossref","first-page":"38270","DOI":"10.18632\/oncotarget.5681","article-title":"MicroRNA-15a\/16-1 cluster located at chromosome 13q14 is down-regulated but displays different expression pattern and prognostic significance in multiple myeloma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.jbo.2020.100327_b0130","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1002\/ijc.29199","article-title":"Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma","volume":"136","author":"Hao","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"21","key":"10.1016\/j.jbo.2020.100327_b0135","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V122.21.5343.5343","article-title":"Circulating microrna 483\u20135p in multiple myeloma as a novel biomarker for diagnosis and predicting survival","volume":"122","author":"Xiaoyan","year":"2013","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0140","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10428194.2012.704030","article-title":"Serum miR-29a as a marker of multiple myeloma","volume":"54","author":"Sevcikova","year":"2013","journal-title":"Leukemia & lymphoma"},{"issue":"2","key":"10.1016\/j.jbo.2020.100327_b0145","first-page":"471","article-title":"Circulating Serum MicroRNA as Diagnostic Biomarkers for Multiple Myeloma","volume":"25","author":"Xu","year":"2017","journal-title":"Zhongguo shi yan xue ye xue za zhi"},{"issue":"3","key":"10.1016\/j.jbo.2020.100327_b0150","first-page":"4001","article-title":"The diagnostic and prognostic value of plasma microRNA-125b-5p in patients with multiple myeloma","volume":"16","author":"Jiang","year":"2018","journal-title":"Oncology letters"},{"issue":"10","key":"10.1016\/j.jbo.2020.100327_b0155","first-page":"1143","article-title":"Expression and clinical significance of serum microRNA-148a in patients with multiple myeloma","volume":"44","author":"Xie","year":"2018","journal-title":"[J]. Jiangsu Medical."},{"issue":"8","key":"10.1016\/j.jbo.2020.100327_b0160","first-page":"903","article-title":"The Diagnostic and Prognostic Value of Plasma MicroRNA497 in Patients with Multiple Myeloma","volume":"51","author":"Cai","year":"2019","journal-title":"[J] Inner Mongolia Med."},{"issue":"12","key":"10.1016\/j.jbo.2020.100327_b0165","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/bjc.2012.525","article-title":"Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma","volume":"107","author":"Jones","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.jbo.2020.100327_b0170","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1515\/cclm-2015-1108","article-title":"Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma","volume":"55","author":"Shen","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"issue":"2","key":"10.1016\/j.jbo.2020.100327_b0175","first-page":"259","article-title":"Studies on the roles of miRNA expression forecast in the multiple myeloma","author":"Bo","year":"2015","journal-title":"Chinese Journal of Laboratory Diagnosis."},{"issue":"7","key":"10.1016\/j.jbo.2020.100327_b0180","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.1016\/j.clml.2020.01.017","article-title":"Consensus Guidelines on the Diagnosis of Multiple Myeloma and Related Disorders: Recommendations of the Myeloma Canada Research Network Consensus Guideline Consortium","volume":"20","author":"Bergstrom","year":"2020","journal-title":"Clinical lymphoma, myeloma & leukemia"},{"issue":"2","key":"10.1016\/j.jbo.2020.100327_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020276","article-title":"miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.jbo.2020.100327_b0190","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the Accuracy of Diagnostic Systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.jbo.2020.100327_b0195","article-title":"Potential diagnostic value of miRNAs in peripheral blood for osteosarcoma: A meta-analysis. Journal of Bone","volume":"23","author":"Gao","year":"2020","journal-title":"Oncology"},{"issue":"12","key":"10.1016\/j.jbo.2020.100327_b0200","first-page":"5003","volume":"108","author":"Arroyo","year":"2011","journal-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma."},{"issue":"1","key":"10.1016\/j.jbo.2020.100327_b0205","first-page":"87","article-title":"The diagnostic value of circulating microRNAs as a biomarker for gastric cancer: A meta-analysis","volume":"41","author":"Wei","year":"2019","journal-title":"Oncol. Rep."}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137420300828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137420300828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:17:41Z","timestamp":1761941861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137420300828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":41,"alternative-id":["S2212137420300828"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100327","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential diagnostic value of circulating miRNA for multiple myeloma: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2020.100327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100327"}}